BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 374283)

  • 21. The direct spectrophotometric observation of benzo(a)pyrene phenol formation by liver microsomes.
    Prough RA; Patrizi VW; Estabrook RW
    Cancer Res; 1976 Dec; 36(12):4439-43. PubMed ID: 1000493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of microsome-mediated benzo[a]pyrene-metabolism by serum.
    Nemoto N; Takayama S
    Carcinogenesis; 1982; 3(4):359-62. PubMed ID: 6284397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of benzo(a)pyrene and 2-acetamidofluorene to mutagens by microsomal preparations from different animal species: role of cytochrome P-450 and P-448.
    Ioannides C; Parkinson C; Parke DV
    Xenobiotica; 1981 Oct; 11(10):701-8. PubMed ID: 6275616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutagenicity of furoquinoline alkaloids in the Salmonella/microsome assay. Mutagenicity of dictamnine is modified by various enzyme inducers and inhibitors.
    Häfele F; Schimmer O
    Mutagenesis; 1988 Jul; 3(4):349-53. PubMed ID: 3062325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microsomal activation of dibenzo[def,mno]chrysene (anthanthrene), a hexacyclic aromatic hydrocarbon without a bay-region, to mutagenic metabolites.
    Platt KL; Degenhardt C; Grupe S; Frank H; Seidel A
    Chem Res Toxicol; 2002 Mar; 15(3):332-42. PubMed ID: 11896680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between benzo(a)pyrene-induced DNA base modification and frequency of reverse mutations in mutant strains of Salmonella typhimurium.
    Fahl WE; Scarpelli DG; Gill K
    Cancer Res; 1981 Sep; 41(9 Pt 1):3400-6. PubMed ID: 6266655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The formation of benzo [a] pyrene - deoxyribonucleoside adducts in vivo and in vitro.
    Ashurst SW; Cohen GM
    Carcinogenesis; 1982; 3(3):267-73. PubMed ID: 6282487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic, additive, and antagonistic mutagenic responses to binary mixtures of benzo(a)pyrene and benzo(e)pyrene as detected by strains TA98 and TA100 in the Salmonella/microsome assay.
    Hass BS; Brooks EE; Schumann KE; Dornfeld SS
    Environ Mutagen; 1981; 3(2):159-66. PubMed ID: 6263605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA--benzo[a]pyrene adducts formed in a Salmonella typhimurium mutagenesis assay system.
    Santella RM; Grunberger D; Weinstein IB
    Mutat Res; 1979 Jul; 61(2):181-9. PubMed ID: 384221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microsome-mediated reactions of phenols of polycyclic hydrocarbons with DNA.
    Hewer A; Phillips DH; Hodgson RM; Grover PL
    Cancer Lett; 1984 Apr; 22(3):321-8. PubMed ID: 6324987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microsomal metabolism of 1-nitrobenzo[e]pyrene to a highly mutagenic K-region dihydrodiol.
    Fu PP; Heflich RH; Von Tungeln LS; Miranda HZ; Evans FE
    Carcinogenesis; 1988 Jun; 9(6):951-8. PubMed ID: 3286032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of UDP-glucuronic acid on the microsome-mediated binding of benzo(a)pyrene metabolites to calf thymus DNA.
    Nemoto N; Hirakawa T; Takayama S
    Carcinogenesis; 1980 Feb; 1(2):115-20. PubMed ID: 22282989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of mutagenic metabolites from benzo(a)pyrene and 2-aminoanthracene by the s-9 fraction from the liver of the Northern pike (Esox lucius): inducibility with 3-methylcholanthrene and correlation with benzo[a]pyrene monooxygenase activity.
    Balk L; Depierre JW; Sundvall A; Rannug U
    Chem Biol Interact; 1982 Jul; 41(1):1-13. PubMed ID: 6284388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyrrolizidine alkaloid-induced alterations in benzo[alpha]pyrene metabolism and binding of benzo[alpha]pyrene metabolites to deoxyribonucleic acid.
    Williams DE; Miranda CL; Buhler DR
    Biochem Pharmacol; 1983 Aug; 32(16):2443-7. PubMed ID: 6311218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A benzo[alpha]pyrene-7,8-dihydrodiol-9,10-epoxide is the major metabolite involved in the binding of benzo[alpha]pyrene to DNA in isolated viable rat hepatocytes.
    Ashurst SW; Cohen GM
    Chem Biol Interact; 1980 Jan; 29(1):117-27. PubMed ID: 7356534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of antioxidants on the metabolism and mutagenicity of benzo[a]pyrene in vitro.
    Rahimtula AD; Zachariah PK; O'Brien PJ
    Biochem J; 1977 May; 164(2):473-5. PubMed ID: 328015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arachidonic acid-dependent activation of benzo[a]pyrene to bind to proteins with cytosolic and microsomal fractions from rat liver and lung.
    Nemoto N; Takayama S
    Carcinogenesis; 1984 Jul; 5(7):961-4. PubMed ID: 6329541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutagenicity and in vivo disposition of biliary metabolites of benzo(a)pyrene.
    Chipman JK; Millburn P; Brooks TM
    Toxicol Lett; 1983 Jul; 17(3-4):233-40. PubMed ID: 6312638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.